Biological Trace Element Research

, Volume 176, Issue 2, pp 350–354 | Cite as

Subchronic Arsenic Exposure Through Drinking Water Alters Lipid Profile and Electrolyte Status in Rats

  • Prashantkumar Waghe
  • Souvendra Nath Sarkar
  • Thengumpallil Sasindran Sarath
  • Kannan Kandasamy
  • Soumen Choudhury
  • Priyanka Gupta
  • Sankarankutty Harikumar
  • Santosh Kumar Mishra
Article

Abstract

Arsenic is a groundwater pollutant and can cause various cardiovascular disorders in the exposed population. The aim of the present study was to assess whether subchronic arsenic exposure through drinking water can induce vascular dysfunction associated with alteration in plasma electrolytes and lipid profile. Rats were exposed to arsenic as 25, 50, and 100 ppm of sodium arsenite through drinking water for 90 consecutive days. On the 91st day, rats were sacrificed and blood was collected. Lipid profile and the levels of electrolytes (sodium, potassium, and chloride) were assessed in plasma. Arsenic reduced high-density lipoprotein cholesterol (HDL-C) and HDL-C/LDL-C ratio, but increased the levels of triglycerides, total cholesterol, low-density lipoprotein cholesterol (LDL-C), and electrolytes. The results suggest that the arsenic-mediated dyslipidemia and electrolyte retention could be important mechanisms in the arsenic-induced vascular disorder.

Keywords

Arsenic Lipid profile Aorta Rats 

Notes

Acknowledgments

The authors are grateful to the Department of Biotechnology (DBT), New Delhi, India, for providing financial support in conducting the study. The fellowship awarded to the first author by the Institute is gratefully acknowledged. The authors are also thankful to the Director, Indian Veterinary Research Institute, for providing necessary facilities.

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflicts of interest.

References

  1. 1.
    Argos M, Kalra T, Rathouz PJ, Chen Y, Pierce B, Parvez F, Islam T, Ahmed A, Rakibuz-Zaman M, Hasan R, Sarwar G, Slavkovich V, Van Geen A, Graziano J, Ahsan H (2010) Arsenic exposure from drinking water, and all-cause and chronic-disease mortalities in Bangladesh (HEALS): a prospective cohort study. Lancet 376:252–258CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Cheng TJ, Chuu JJ, Chang CY, Tsai WC, Chen KJ, Guo HR (2011) Atherosclerosis induced by arsenic in drinking water in rats through altering lipid metabolism. Toxicol App Pharmacol 256:146–153CrossRefGoogle Scholar
  3. 3.
    Mukherjee A, Sengupta MK, Hossain MA, Ahamed S, Das B, Nayak B, Lodh D, Rahman MM, Chakraborti D (2006) Arsenic contamination in groundwater: a global perspective with emphasis on the Asian scenario. J Health Popul Nutr 24:142–163PubMedGoogle Scholar
  4. 4.
    WHO (2010) Exposure to arsenic: a major public health concern Geneva: WHO Press. Available: http://www.who.int/ipcs/assessment/ public health/arsenic/en/. Accessed on 23 Oct 2013
  5. 5.
    Rahaman S, Sinha AC, Pati R, Mukhopadhyay D (2013) Arsenic contamination: a potential hazard to the affected areas of West Bengal, India. Environ Geochem Health 35:119–132CrossRefPubMedGoogle Scholar
  6. 6.
    Chatterjee A, Chatterji U (2010) Arsenic abrogates the estrogen-signaling pathway in the rat uterus. Reprod Biol Endocrinol 8:80. doi: 10.1186/1477-7827-8-80 CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Guha Mazumder D, Dasgupta UB (2011) Chronic arsenic toxicity: studies in West Bengal, India. Kaohsiung. J Med Sci 27:360–370Google Scholar
  8. 8.
    Alam MG, Allinson G, Stagnitti F, Tanaka A, Westbrooke M (2002) Arsenic contamination in Bangladesh groundwater: a major environmental and social disaster. Int J Environ Health Res 12:235–153CrossRefPubMedGoogle Scholar
  9. 9.
    Chen Y, Parvez F, Gamble M, Islam T, Ahmed A, Argos M, Graziano JH, Ahsan H (2009) Arsenic exposure at low-to-moderate levels and skin lesions, arsenic metabolism, neurological functions, and biomarkers for respiratory and cardiovascular diseases: review of recent findings from the health effects of arsenic longitudinal study (HEALS) in Bangladesh. Toxicol Appl Pharmacol 239:184–192CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Stea F, Bianchi F, Cori L, Sicari R (2014) Cardiovascular effects of arsenic: clinical and epidemiological findings. Environ Sci Pollut Res Int 21:244–251CrossRefPubMedGoogle Scholar
  11. 11.
    Michel T, Hoffman BB (2012) Treatment of myocardial ischemia and hypertension. In: Goodman and Gilman’s The Pharmacological Basis of Therapeutics. In: Brunton LL, Chabner BA, Knollmann BC (eds) 12th edn. The Mc Graw Hill Company, pp 765–766Google Scholar
  12. 12.
    Zhao C, Dahlman-Wright K (2010) Liver X receptor in cholesterol metabolism. J Endocrinol 204:233–240CrossRefPubMedGoogle Scholar
  13. 13.
    Waghe P, Sarath TS, Gupta P, Kandasamy K, Choudhury S, Kutty HS, Mishra SK, Sarkar SN (2015) Arsenic causes aortic dysfunction and systemic hypertension in rats: augmentation of angiotensin II signaling. Chem Biol Interact 237:104–114CrossRefPubMedGoogle Scholar
  14. 14.
    Halperin RO, Sesso HD, Ma J, Buring JE, Stampfer MJ, Gaziano JM (2006) Dyslipidemia and the risk of incident hypertension in men. Hypertens 47:45–50CrossRefGoogle Scholar
  15. 15.
    Chattopadhyay S, Maiti S, Maji G, Deb B, Pan B, Ghosh D (2011) Protective role of Moringa oleifera (Sajina) seed on arsenic-induced hepatocellular degeneration in female albino rats. Biol Trace Elem Res 142:200–212CrossRefPubMedGoogle Scholar
  16. 16.
    Muthumani M, Prabu SM (2014) Silibinin potentially attenuates arsenic-induced oxidative stress mediated cardiotoxicity and dyslipidemia in rats. Cardiovasc Toxicol 14:83–87CrossRefPubMedGoogle Scholar
  17. 17.
    Sarath TS, Waghe P, Gupta P, Choudhury S, Kannan K, Pillai AH, Harikumar SK, Mishra SK, Sarkar SN (2014) Atorvastatin ameliorates arsenic-induced hypertension and enhancement of vascular redox signaling in rats. Toxicol Appl Pharmacol 280:443–454CrossRefPubMedGoogle Scholar
  18. 18.
    Mann KK, Padovani MS, Guo Q, Colosimo AL, Ho-Young L, Kurie JM, Miller WH (2005) Arsenic trioxide inhibits nuclear receptor function via SEK1/JNK mediated RXRα phosphorylation. J Clin Invest 115:2924–2933CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Padovani AM, Molina MF, Mann KK (2010) Inhibition of liver x receptor/retinoid X receptor-mediated transcription contributes to the proatherogenic effects of arsenic in macrophages in vitro. Arterioscler Thromb Vasc Biol 30:1228–1236CrossRefPubMedGoogle Scholar
  20. 20.
    Nain S, Smits JE (2012) Pathological, immunological and biochemical markers of subchronic arsenic toxicity in rat. Environ Toxicol 27:244–254CrossRefPubMedGoogle Scholar
  21. 21.
    Burtis CA, Ashwood CR, Burns DE (2006) Textbook of clinical chemistry and molecular diagnostics, 4th edn. Saunders, New DelhiGoogle Scholar
  22. 22.
    Guyton AC, Hall JE (2006) Textbook of medical physiology, 11th edn. W. B. Saunders, Philadelphia, pp. 365–381Google Scholar
  23. 23.
    Williams GH, Dluhy RG (1972) Aldosterone biosynthesis. Interrelationship of regulatory factors. Am J Med 53:595–605CrossRefPubMedGoogle Scholar
  24. 24.
    Harrison-Bernard LM (2009) The renal renin-angiotensin system. Adv Physiol Educ 33:270–274CrossRefPubMedGoogle Scholar
  25. 25.
    Naujokas MF, Anderson B, Ahsan H, Aposhian HV, Graziano JH, Thompson C, Suk WA (2013) The broad scope of health effects from chronic arsenic exposure: update on a worldwide public health problem. Environ Health Perspect 121:295–302CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Lubin MF, Walker HK, Smith BR (2006) Medical Management of the Surgical Patient. Cambridge University Press, Cambridge, pp. 333–359CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Prashantkumar Waghe
    • 1
  • Souvendra Nath Sarkar
    • 2
  • Thengumpallil Sasindran Sarath
    • 2
  • Kannan Kandasamy
    • 2
  • Soumen Choudhury
    • 2
  • Priyanka Gupta
    • 2
  • Sankarankutty Harikumar
    • 2
  • Santosh Kumar Mishra
    • 2
  1. 1.Department of Veterinary Pharmacology and ToxicologyVeterinary CollegeShimogaIndia
  2. 2.Division of Pharmacology and ToxicologyIndian Veterinary Research InstituteBareillyIndia

Personalised recommendations